GeneCreek will be attending the 2018 Vitafoods Europe meeting which will be held 15-17 May 2018, in Geneva, Switserland. https://www.vitafoods.eu.com/en/welcome.html
GeneCreek participates in the 2018 Preclinical Development of Immunotherapies meeting which will be held at April 24 in Lyon, France. The meeting is co-organized by Mabdesign and Lyonbiopole and features B2B meetings. https://preclinique-immunotherapies2018.b2match.io/
GeneCreek filed a provisional patent application Nr. 62631877 with the USPTO entitled “PROBIOTIC COMPOSITION AND USE THEREOF FOR THE PRIMARY PREVENTION AND IMPROVEMENT OF PEDIATRIC ALLERGY”.
GeneCreek filed a provisional patent application Nr. 62617183 with the USPTO entitled “PHARMACEUTIC COMPOSITION AND USE THEREOF FOR PREVENTING AND IMPROVING THE SYNDROME OF CLOSTRIDIUM DIFFICILE INFECTION”.
GeneCreek presents at the 2018 Probiotics & Intestinal Microbiota workshop, taking place on Feb. 6th 2018 in Lyon. https://lyonbiopole.com/agenda/atelier-thematique-probiotiques-microbiotes-intestinal